Chapter 172
Chapter 172
“No need.” Das turned on the tap.
Ryan waited anxiously at the door.
It wasn’t until the water stopped running that Ryan heard Das moving the stool. He knocked on the door again. “Can |e
in?”
“Pleasee in.”
Ryan opened the door and saw the little boy dripping wet, wrapped in a bear-themed towel.
He looked as cute as a baby bear himself with the bear hat on his head, but his face still had a touch of
coolness.
“Is there anything you need?” Das asked.
“It’s a little dangerous for children to use a hairdryer. Let me help you dry your hair.” Ryan plugged in the hairdryer and removed
Das‘ hat to blow dry his hair.
He nced up into the mirror, observing Ryan as he blow—dried his hair, the older man’s hands delicately tousling his locks.
It felt...fortable.
After drying his hair and brushing his teeth, Das headed out with his pajamas in hand. “I''ll go change. You hurry up and take a
shower!”
“Alright.” Ryan smiled as he watched Das’ retreating figure.
By the time Ryan finished showering and came out, Das had already fallen asleep.
Das looked exactly like Lily when he was asleep, except Das’ eyebrows were slightly thicker.
Although both kids were as delicate as dolls, you could still tell that Das was a little boy.
Ryan kissed Das‘ chubby cheek and tucked him in. He theny beside him, carefully embracing him
as he did with Lily.Property ? 2024 N0(v)elDrama.Org.
In Ryan’s eyes, Das and Lily were his treasures.
On the 29th, the Evergreen Biotech hearing took ce in Meria. This was led by Derek Cooper, who
oversaw thepany’s operations in Eurindel and Meria.
The hearing was broadcast worldwide.
Audrey stood before her juicer, watching Derek on the TV screen. She sipped the fruit and vegetable juice, not paying too much
attention to the hearing.
However, the news in Meria had already exploded.
Chapter 122
2/2
People spontaneously organized demonstrations outside the Meria Congress building, rallying to support Evergreen Biotech.
The reason was simple: Evergreen Biotech’s technology had saved many lives.
Audrey had been slowly releasing news half a month ago.
News outlets published that if Evergreen Biotech did not receive a fair trial in Meria, they wouldpletely withdraw from the
local market, terminating all coborations with major universities and hospitals—even at the cost of paying hefty breach—of—
contract penalties.
This matter concerned everyone’s life, so the public wouldn''t sit idly by. After all, who could guarantee that they wouldn’t suffer
from a terminal illness in their lifetime?
Currently, only Evergreen Biotech had drug forms to treat cancer and Alzheimer’s disease. Even drugs that could control ALS
were in clinical trials.
If Evergreen Biotech left the Meria market, what would happen if people got sick and didn’t have medicine?
Perhaps they would eventually develop new drugs, but who could guarantee they wouldn’t fall ill before the new drugs were
developed?
These people supported Evergreen Biotech not just to show solidarity, but also to give themselves some hope.